PL3287471T3 - Polisacharyd odpowiedni do modulacji odpowiedzi immunologicznej - Google Patents

Polisacharyd odpowiedni do modulacji odpowiedzi immunologicznej

Info

Publication number
PL3287471T3
PL3287471T3 PL17189957T PL17189957T PL3287471T3 PL 3287471 T3 PL3287471 T3 PL 3287471T3 PL 17189957 T PL17189957 T PL 17189957T PL 17189957 T PL17189957 T PL 17189957T PL 3287471 T3 PL3287471 T3 PL 3287471T3
Authority
PL
Poland
Prior art keywords
immune response
modulate immune
polysaccharide suitable
polysaccharide
modulate
Prior art date
Application number
PL17189957T
Other languages
English (en)
Inventor
Ruud Albers
Jari Helin
Werner Klaffke
Jean Hypolites Koek
Petronella Anna Kreijveld
Jari Natunen
Richardus Paulus Anton Oranje
Erwin Werner Tareilus
Original Assignee
Nutrileads B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrileads B.V. filed Critical Nutrileads B.V.
Publication of PL3287471T3 publication Critical patent/PL3287471T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • C08B37/0048Processes of extraction from organic materials
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL17189957T 2009-12-11 2010-11-16 Polisacharyd odpowiedni do modulacji odpowiedzi immunologicznej PL3287471T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP09178876 2009-12-11
EP17189957.8A EP3287471B1 (en) 2009-12-11 2010-11-16 Polysaccharide suitable to modulate immune response
EP10776375A EP2510014A1 (en) 2009-12-11 2010-11-16 Polysaccharide suitable to modulate immune response
PCT/EP2010/067528 WO2011069781A1 (en) 2009-12-11 2010-11-16 Polysaccharide suitable to modulate immune response

Publications (1)

Publication Number Publication Date
PL3287471T3 true PL3287471T3 (pl) 2021-08-02

Family

ID=42111328

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17189957T PL3287471T3 (pl) 2009-12-11 2010-11-16 Polisacharyd odpowiedni do modulacji odpowiedzi immunologicznej

Country Status (7)

Country Link
US (3) US9260535B2 (pl)
EP (2) EP3287471B1 (pl)
CN (1) CN102762597A (pl)
DK (1) DK3287471T3 (pl)
ES (1) ES2858461T3 (pl)
PL (1) PL3287471T3 (pl)
WO (1) WO2011069781A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101168381B1 (ko) * 2011-04-25 2012-07-27 주식회사 비티씨 녹차 가수분해물의 면역기능 증강 및 식품 조성물 제조 방법
CN103890011B (zh) * 2011-10-20 2016-05-11 不二制油株式会社 水溶性大豆多糖类及其制造方法
US20150065451A1 (en) * 2012-03-28 2015-03-05 The Research Foundation Of State University Of New York Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation
WO2014012755A1 (en) 2012-07-18 2014-01-23 Unilever N.V. An edible product
WO2014021795A1 (en) * 2012-08-01 2014-02-06 Asian Phytoceuticals Public Company Limited Method of administrating a series of compositions for dynamic immune modulation
EP2931376B1 (en) 2012-12-17 2017-07-26 Unilever N.V. Topical composition
CN104837528B (zh) * 2012-12-17 2020-03-03 荷兰联合利华有限公司 外用组合物
CA2924597A1 (en) * 2013-09-19 2015-03-26 The Research Foundation For The State University Of New York Methods and materials for treating diabetes or liver steatosis
JP2017525702A (ja) * 2014-08-18 2017-09-07 ファーマジェネシス, インコーポレイテッド ポリガラクツロナンラムノガラクツロナン(pgrg1)組成物
AU2016243516A1 (en) 2015-03-27 2017-11-09 The Research Foundation For The State University Of New York Methods and materials for reducing amyloid beta levels within a mammal
JP6788882B2 (ja) * 2016-08-09 2020-11-25 イマジン・グローバル・ケア株式会社 自然免疫活性化作用を有する多糖類及び該多糖類を含有する自然免疫活性化剤又は飲食品
ES2982721T3 (es) 2017-10-23 2024-10-17 Nutrileads B V Método de producción de un aislado de polisacárido péctico enriquecido en ramnogalacturonano-I
ES2987601T3 (es) * 2017-10-23 2024-11-15 Nutrileads B V Polisacáridos pécticos hidrolizados enzimáticamente para el tratamiento o la prevención de infecciones
CN111447935A (zh) 2017-12-04 2020-07-24 纽崔利兹有限公司 用于预防或治疗沙门氏菌病的组合物
CN112739417B (zh) 2018-09-07 2025-07-01 纽崔利兹有限公司 用于调节肠道微生物群的益生元
CN113480674B (zh) * 2021-08-19 2022-03-08 中南大学 一种黑茶多糖-ⅰ活性成分及其制备方法和在抗癌中应用
FR3126869A1 (fr) 2021-09-16 2023-03-17 Gozen K. K. Japan Composition pharmaceutique comprenant des métabolites issus de la bactérie Bacillus subtilis Gozen GZN-08 isolée de Camellia sinensis et modulant la réponse immunitaire.
AU2023379925A1 (en) 2022-11-15 2025-06-05 Nutrileads B.V. Prebiotic composition for stabilizing a healthy gut microbiota

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3360899B2 (ja) * 1993-10-08 2003-01-07 日本医薬品工業株式会社 癌予防・治療剤
JPH089226A (ja) 1994-06-15 1996-01-12 Fuji Photo Optical Co Ltd カメラの遠隔操作制御装置
US6794495B1 (en) 1998-10-19 2004-09-21 New Nordic Danmark Aps Composition comprising extensin and, optionally, pectic polysaccharides
US20030159178A1 (en) 2000-02-10 2003-08-21 Peter Ulvskov Method for remodelling cell wall polysaccharide structures in plants
DE10019076A1 (de) 2000-04-06 2001-10-18 Lang Christine Verwendung von Polygalakturoniden als Lebensmittelzusatzstoffe
CN100548329C (zh) * 2002-03-29 2009-10-14 城田安幸 免疫激活剂药剂及保健饮食品
JP2004107295A (ja) 2002-09-20 2004-04-08 National Agriculture & Bio-Oriented Research Organization ヒスタミン遊離抑制剤
US20050182037A1 (en) * 2002-10-16 2005-08-18 Alan Fergusson Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
AU2004231997A1 (en) 2003-04-16 2004-11-04 The University Of Mississippi Immunostimulatory agents in botanicals
US7141264B2 (en) * 2003-06-02 2006-11-28 Unilever Bestfoods, North America, Division Of Conopco, Inc. Functional water
US20080113044A1 (en) 2006-03-23 2008-05-15 Alberte Randall S Extracts and Methods Comprising Green Tea Species
EP2214508A1 (en) 2007-12-07 2010-08-11 Unilever N.V. Edible product having an immunostimulating effect
US20100316660A1 (en) 2007-12-20 2010-12-16 Johanna Alida Van Adrichem Edible product having an immunostimulating effect

Also Published As

Publication number Publication date
EP2510014A1 (en) 2012-10-17
WO2011069781A1 (en) 2011-06-16
ES2858461T3 (es) 2021-09-30
EP3287471A1 (en) 2018-02-28
EP3287471B1 (en) 2020-12-16
US10098948B2 (en) 2018-10-16
US9260535B2 (en) 2016-02-16
US20180339040A1 (en) 2018-11-29
US20130064858A1 (en) 2013-03-14
DK3287471T3 (da) 2021-01-11
CN102762597A (zh) 2012-10-31
US20160151485A1 (en) 2016-06-02
US10449249B2 (en) 2019-10-22

Similar Documents

Publication Publication Date Title
PL3287471T3 (pl) Polisacharyd odpowiedni do modulacji odpowiedzi immunologicznej
ZA201208525B (en) Antibodies to human gdf8
IL215696A0 (en) Antibodies specific to cadherin-17
IL219288A0 (en) Composition to induce specific immune tolerance
IL214779A0 (en) Fully human antibodies specific to cadm1
EP2413019A4 (en) SOLAR SIMULATOR WITH VARIABLE SPECTRUM
PL2546231T3 (pl) Pochodna alkiloaminy
PT2542591T (pt) Derivados silílicos de polissacáridos
WO2011085063A9 (en) Immune modulators relating to foxo3a
GB0919733D0 (en) Immune system modulating composition
GB201013445D0 (en) Made to go!
GB201002561D0 (en) Easy to find invisible contact lens
GB2481592B (en) Improvements relating to equalizers
GB0902541D0 (en) Methods to identify modulators
GB2485164B (en) Improvements in or relating to luminaires
GB201020363D0 (en) Improvements to fittings
GB201011949D0 (en) Improvements to sandbags
GB201016181D0 (en) Milk to go
GB201009110D0 (en) Improvements in or relating to boiler installations
GB0919335D0 (en) Device to produce culture supplement
AU2010902717A0 (en) Stimulating immune response
GB0915340D0 (en) Polysaccharides
GB201116475D0 (en) Applying pressure garments to limbs
GB201009212D0 (en) Methods to identify modulators
GB201009211D0 (en) Methods to identify modulators